CMTM

End Drug Shortages Alliance Releases Market Assessment for Drugs Impacted by Manufacturing Plant Closure

Retrieved on: 
Tuesday, May 17, 2022
Other Manufacturing, Medical Supplies, Hospitals, Transport, Manufacturing, Practice Management, Health, Pharmaceutical, Logistics, Supply Chain Management, Diabetes, Risk, Teva, Patient, Solution, Adult, Pharmacy, Media, Oklahoma Hospital Association, Industry, Organization, Pancreatic neuroendocrine tumor, Cancer, CMTM, East End Drugs, Pharmaceutical industry, Risk management, Medicine, Alliance

The End Drug Shortages Alliance today announced it has released a market analysis of products affected by a recent Teva pharmaceutical manufacturing plant closure in Irvine, Calif.

Key Points: 
  • The End Drug Shortages Alliance today announced it has released a market analysis of products affected by a recent Teva pharmaceutical manufacturing plant closure in Irvine, Calif.
  • Information shared in this report highlights the level of transparency that is required across the supply chain to successfully navigate drug shortages.
  • All Alliance workstreams are aligned to the organizations objectives, including:
    Transparency and redundancy, including an early alert system for drug shortages.
  • To learn more about the End Drug Shortages Alliance, email [email protected] .

End Drug Shortages Alliance Announces Board of Directors, Mission, Vision Statements in First All-Member Meeting

Retrieved on: 
Tuesday, May 3, 2022
Practice Management, Pharmaceutical, Medical Supplies, General Health, Health, Hospitals, Supply Chain Management, Retail, Board, Communication, Senior, ASHP, CMTM, Assistant professor, American Pharmacists Association, MS, Mayo Clinic, Patient, Doctor of Philosophy, Association, Organization, Program, Pharmacist, Industry, FCCP, MD, Oklahoma Hospital Association, East End Drugs, Alliance, MBA, Vizient, Inc., Solution, CEO, JD, American, Doctor of Pharmacy, Risk, Management, Medicine, Medical device, Pharmacy

"The Alliance has generated a lot of excitement from across the industry for resolving the persistent issue of drug shortages," said Tichy.

Key Points: 
  • "The Alliance has generated a lot of excitement from across the industry for resolving the persistent issue of drug shortages," said Tichy.
  • The End Drug Shortages Alliance was launched in November to address the ongoing crisis and more than 70 organizations have joined to date.
  • Collectively we will end drug shortages through focus on transparency, communication, quality, redundancy and production of additional supply to achieve measurable and sustainable results.
  • The outpouring of support for the End Drug Shortages Alliance throughout the industry has been tremendous, said Mittal Sutaria, Vizient senior vice president, pharmacy contract and program solutions and End Drug Shortages Alliance board member.